G Medical Innovations Holdings Ltd · OTC:GMVDF

G Medical Innovations — Investor Presentation (April 2023)

26 slides from G Medical Innovations's investor presentation, April 2023

  1. Slide 1: Investor Presentation

    MEDICAL April 2023 INVESTOR PRESENTATION Nasdaq: GMVD

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements All statements in this presentation, other than those relating to historical facts, are "forward‐looking statements.” Words such as “may,” “will,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar expressions or variations of such

  3. Slide 3: Company Overview

    Company Overview G Medical is a Next-Generation Tele-Health and At-Home Testing Company • We develop and market clinical and consumer medical-grade remote monitoring systems focused on chronic diseases as well as develop and Digital health devices and monitoring market at-home testing kits which wil

  4. Slide 4: Recent Developments

    Recent Developments Collaborations with MiCare Path and AdventHealth Central Florida Announced in March 2023 • Goal is to provide innovative remote patient monitoring • Goal is to provide innovative remote patient monitoring solutions globally. solutions for AdventHealth patients in central Florida.

  5. Slide 5: Rapidly Rising US Population HealthCare Risk

    Rapidly Rising US Population HealthCare Risk • 900,000 annual deaths due to heart diseases • 183,000 annual deaths related to AFIB • 12M AFIB patients by 2030 • 1 of 2 Americans have high BP (116M) • $147B loss of productivity • +37M Americans have diabetes • 96M (1 of 3) Americans are prediabetes –

  6. Slide 6: Rapidly Rising US Healthcare Cost

    Rapidly Rising US Healthcare Cost US National Health Expenditure ("NHE") Is Projected To Reach $6.2 Trillion by 2028 • Health spending in the United States is expected to grow Forecasted national health expenditure 2021-2028 at a pace of 1.1% year over year faster than U.S. GDP. • Healthcare spendin

  7. Slide 7: Tele-Health & At-Home Testing – Paradigm Shift Towards Solving the Problem

    Tele-Health & At-Home Testing – Paradigm Shift Towards Solving the Problem • At-Home hospitalization cost for acute care episodes • Physicians, on average, regularly use almost twice is approximately 40% lower than hospital admission the number of digital “health tools” in 2022, vs. costs for those

  8. Slide 8: Tele-Health & At-Home Testing – A Strong Reimbursement Incentive

    Tele-Health & At-Home Testing – A Strong Reimbursement Incentive Our Devices Have Gained CPT Code Reimbursement Approval at more than 150 of the Leading HealthCare Insurance Providers “Over the last few years, I have witnessed a marked willingness by insurers to reimburse for lower-cost and, in many

  9. Slide 9: Our Tele-Health Devices and Monitoring Solutions

    Our Tele-Health Devices and Monitoring Solutions Spider • Devices share data • Medicare-Certified between patients and independent doctors diagnostic testing facilities • AI based algorithms for real-time alerts G-Patch • Continuous • FDA cleared Monitoring Online and Call Center • Patented technolo

  10. Slide 10: Our Tele-Health Devices and Monitoring Solutions

    Our Tele-Health Devices and Monitoring Solutions How it Works in a Real-Life Situation… Meet Jeff Jeff gets his device delivered to his house Jeff’s insurance carrier approves Jeff’s vital information is transmitted to his doctor via the cloud Jeff’s doctor prescribes a G Medical device Jeff (68) su

  11. Slide 11: How We Measure Up In the Tele-Health Landscape

    How We Measure Up In the Tele-Health Landscape We believe that we are the only one-stop shop multifunctional platform of devices and monitoring services to enable the highest data monetization across the entire tele-health ecosystem MEDICAL (Not Approved by the FDA) Real Time Abnormal ECG Detection

  12. Slide 12: Our Recent Penetration into the US Healthcare System

    Our Recent Penetration into the US Healthcare System A Few Recent Distribution & Partner Wins • Three-year agreement with • Agreement with All County • Pilot program with UnityPoint • Joint development, LiveCare, a U.S.-based Health Care of New York, a Health, the cardiovascular licensing and distri

  13. Slide 13: The At-Home Testing Kit Market & Our Kit Developments

    The At-Home Testing Kit Market & Our Kit Developments • In the second half of 2022, we decided to focus on comprehensive home testing solutions as part of our vision to move towards a home-based healthcare system. • We have developed a wide range of consumer focused At-Home Testing Kits used to coll

  14. Slide 14: Key Features of Our At-Home Testing Kits

    Key Features of Our At-Home Testing Kits 31 Testing Kits … 1. Thyroid 2. Colon Cancer Screening 3. Indoor/Outdoor Allergy 4. Extensive Fitness • Price range from $49 - $259. 5. Heart Health 6. HbA1c • Samples will be delivered to and processed by our CLIA 7. Sleep and Stress certified lab, once oper

  15. Slide 15: How it Works

    How it Works Login to the Purchase the Send test portal with home test kit sample to your Register your Perform the Get results in the online the lab in username kit test online in days or in a retail pre-paid and store shipping bag password 15

  16. Slide 16: Sales Consulting Agreement with Ideaology 360

    Sales Consulting Agreement with Ideaology 360 • Ideaology 360 has accumulated extensive experience & relationships in marketing health and wellness products. • Ideaology 360’s client’s products have achieved sales in excess of $1 billion in the US retail market. • Retail sales network currently repr

  17. Slide 17: At-Home Testing Kit Comparable Company

    At-Home Testing Kit Comparable Company Everlywell is a direct-to-consumer health testing company that connects people with accessible, innovative, and insightful at-home lab tests.1 Everlywell, whose founder appeared on entrepreneur-oriented television show “Shark Tank,” announced a financing round

  18. Slide 18: Management Team

    Management Team Dr. Yacov Geva, CEO, Executive Director A well-known pioneer in the industry of Medical Devices and remote monitoring services, and co-founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd.). Successfully led LifeWatch to an IPO. Dr. Geva holds a B.Sc i

  19. Slide 19: Board of Directors

    Board of Directors Dr. Kenneth R. Melani Non-Executive Chairman, began his career in 1981 as a practicing physician growing his internal medicine practice into the largest multi-specialty physician practice in Western Pennsylvania. In the mid 1980’s he helped start a physician hospital organization,

  20. Slide 20: Appendix

    MEDICAL Appendix 20

  21. Slide 21: Management Team Cont.

    MANAGEMENT TEAM CONT. Tim Lohman, VP Operation G Medical Diagnostic Mr. Lohman has served in various roles in the healthcare industry for 40 years, specifically in remote diagnostic services. Lohman received his technical background as a biomedical equipment specialist in the U.S. Army and National

  22. Slide 22: Intellectual Property

    INTELECTUAL PROPERTY A wide and Patent strong patent Name Country list Patent Number/ Statusthat protect our Application Number pro Product d Type of ucts and services Protection Expiration date SYSTEMS AND METHODS FOR VITAL SIGNS United states Granted 10251603 VSMS Utility patent 30/2/2036 MONITORI

  23. Slide 23: Web Portal for Patients and Physicians

    WEB PORTAL FOR PATIENTS AND PHYSICIANS PATIENT PORTAL PHYSICIAN PORTAL Profile and Main Menu Quick View to last 5 tests - Patients' medical history Abnormal measurements View and Edit click will load results to with option to edit and view for indication based on flexible current page comprehensive

  24. Slide 24: Growth of AFib Prevalence in the USA

    GROWTH OF AFIB PREVALENCE IN THE USA https://www.revespcardiol.org/en-atrial-fibrillation-is-it-an-articulo-13131641 24

  25. Slide 25: Prevalence of AFib Will Only Increase in the Future

    PREVALENCE OF AFIB WILL ONLY INCREASE IN THE FUTURE WITH AGING POPULATION AND LIFESTYLE RELATED COMORBIDITY AFIB incidence rapidly rising Millennials are less healthy 2than (2006-2018) 1 age matched Gen Xers Between millennials and Gen Xers: Data show higher prevalence rates among millennials for 8

  26. Slide 26: Identifying and Treating AFib Early Is Critical

    IDENTIFYING AND TREATING AFIB EARLY IS CRITICAL TO ACHIEVING BETTER OUTCOMES FOR PATIENTS, PROVIDERS AND PAYERS Incidence of death from cardiovascular causes, stroke, or hospitalization reduced with early rhythm control Early rhythm-control therapy Death or hospitalization for associated with a lowe

G Medical Innovations Holdings — Investor Presentation (April 2023) on 6ix